1. Home
  2. VSTM vs ICHR Comparison

VSTM vs ICHR Comparison

Compare VSTM & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • ICHR
  • Stock Information
  • Founded
  • VSTM 2010
  • ICHR 1999
  • Country
  • VSTM United States
  • ICHR United States
  • Employees
  • VSTM N/A
  • ICHR N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • ICHR Semiconductors
  • Sector
  • VSTM Health Care
  • ICHR Technology
  • Exchange
  • VSTM Nasdaq
  • ICHR Nasdaq
  • Market Cap
  • VSTM 598.2M
  • ICHR 581.2M
  • IPO Year
  • VSTM 2012
  • ICHR 2016
  • Fundamental
  • Price
  • VSTM $8.94
  • ICHR $19.61
  • Analyst Decision
  • VSTM Strong Buy
  • ICHR Strong Buy
  • Analyst Count
  • VSTM 9
  • ICHR 6
  • Target Price
  • VSTM $13.38
  • ICHR $29.80
  • AVG Volume (30 Days)
  • VSTM 1.7M
  • ICHR 1.1M
  • Earning Date
  • VSTM 11-05-2025
  • ICHR 11-03-2025
  • Dividend Yield
  • VSTM N/A
  • ICHR N/A
  • EPS Growth
  • VSTM N/A
  • ICHR N/A
  • EPS
  • VSTM N/A
  • ICHR N/A
  • Revenue
  • VSTM $2,137,000.00
  • ICHR $929,180,000.00
  • Revenue This Year
  • VSTM $88.50
  • ICHR $14.64
  • Revenue Next Year
  • VSTM $398.66
  • ICHR $5.82
  • P/E Ratio
  • VSTM N/A
  • ICHR N/A
  • Revenue Growth
  • VSTM N/A
  • ICHR 15.45
  • 52 Week Low
  • VSTM $2.54
  • ICHR $13.12
  • 52 Week High
  • VSTM $11.25
  • ICHR $36.48
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 53.26
  • ICHR 52.96
  • Support Level
  • VSTM $8.49
  • ICHR $16.52
  • Resistance Level
  • VSTM $9.14
  • ICHR $21.42
  • Average True Range (ATR)
  • VSTM 0.43
  • ICHR 1.03
  • MACD
  • VSTM -0.10
  • ICHR 0.20
  • Stochastic Oscillator
  • VSTM 54.31
  • ICHR 46.73

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

Share on Social Networks: